10-Q · 2026-11-09
AN2 Therapeutics reveals its Q3 financial results, showcasing operational progress and future growth strategies in the pharmaceutical sector.
| Name | AN2 Therapeutics, Inc. |
|---|---|
| CIK | 0001880438 |
| Tickers | ANTX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 820606654 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (650) 331-9090 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
AN2 Therapeutics reveals its Q3 financial results, showcasing operational progress and future growth strategies in the pharmaceutical sector.
AN2 Therapeutics, Inc. releases its financial results for Q3 2026, indicating growth potential in the pharmaceutical preparations sector.
390 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000048 | 005-93617 | 261560394 | 34 | 15656 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-127408 | 005-93617 | 261554940 | 34 | 18905 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-461157 | 005-93617 | 261554454 | 34 | 6885 | |||
| 2026-11-09 | 10-Q | 10-Q | 0001193125-26-452664 | 001-41331 | 261533828 | 34 | 9929168 | 1 | 1 | |
| 2026-11-09 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-452660 | 001-41331 | 261533824 | 34 | 372451 | 1 | 1 |
| 2026-11-06 | 4 | 4 | 0001193125-26-452184 | 5703 | ||||||
| 2026-10-13 | 4 | 4 | 0001193125-26-420643 | 4694 | ||||||
| 2026-10-13 | 4 | 4 | 0001193125-26-420641 | 4702 | ||||||
| 2026-10-13 | 4 | 4 | 0001193125-26-420639 | 7436 | ||||||
| 2026-09-16 | 4 | 4 | 0001193125-26-393274 | 7429 | ||||||
| 2026-09-14 | S-8 | S-8 | 0001880438-26-000002 | 333-298920 | 261377395 | 33 | 806746 | 1 | 1 | |
| 2026-09-11 | 4 | 4 | 0001193125-26-389545 | 8696 | ||||||
| 2026-09-08 | 4 | 4 | 0001193125-26-385511 | 12010 | ||||||
| 2026-09-04 | 4 | 4 | 0001193125-26-383697 | 5827 | ||||||
| 2026-09-02 | 4 | 4 | 0001193125-26-380595 | 4507 | ||||||
| 2026-08-27 | 3 | 3 | 0001193125-26-370943 | 3152 | ||||||
| 2026-08-19 | 4 | 4 | 0001193125-26-357225 | 8700 | ||||||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001972481-26-000263 | 001-41331 | 261286962 | 33 | 6133 | |||
| 2026-08-14 | 4 | 4 | 0001193125-26-351801 | 5563 | ||||||
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-344569 | 001-41331 | 261263092 | 34 | 9264793 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-344549 | 001-41331 | 261263051 | 34 | 364570 | 1 | 1 |
| 2026-07-10 | 4 | 4 | 0001193125-26-301167 | 7436 | ||||||
| 2026-07-10 | 4 | 4 | 0001193125-26-301166 | 4694 | ||||||
| 2026-07-10 | 4 | 4 | 0001193125-26-301165 | 4702 | ||||||
| 2026-07-10 | 4 | 4 | 0001193125-26-301092 | 5696 | ||||||
| 2026-06-09 | 8-K | 8-K | 5.07 | 0001193125-26-262264 | 001-41331 | 261073917 | 34 | 164225 | 1 | 1 |
| 2026-06-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-257430 | 001-41331 | 261065182 | 34 | 191613 | 1 | 1 |
| 2026-06-02 | 4 | 4 | 0001193125-26-253622 | 5824 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002073679-26-000066 | 005-93617 | 26990604 | 34 | 6532 | |||
| 2026-05-11 | 10-Q | 10-Q | 0001193125-26-216755 | 001-41331 | 26963222 | 34 | 8127142 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-216752 | 001-41331 | 26963162 | 34 | 310292 | 1 | 1 |
| 2026-04-22 | ARS | ARS | 0001193125-26-170328 | 001-41331 | 26883670 | 34 | 796433 | |||
| 2026-04-22 | DEFA14A | DEFA14A | 0001193125-26-170321 | 001-41331 | 26883657 | 34 | 221872 | |||
| 2026-04-22 | DEF 14A | DEF 14A | 0001193125-26-170314 | 001-41331 | 26883643 | 34 | 1876391 | 1 | 1 | |
| 2026-04-20 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001256 | 333-294956 | 26876626 | 33 | 1733 | ||
| 2026-04-20 | 424B3 | 424B3 | 0001193125-26-164101 | 333-294956 | 26875472 | 33 | 494498 | |||
| 2026-04-20 | 424B5 | 424B5 | 0001193125-26-164095 | 333-294956 | 26875455 | 33 | 488209 | |||
| 2026-04-16 | CORRESP | filename1.htm | 0001193125-26-158794 | 7193 | ||||||
| 2026-04-15 | UPLOAD | filename1.pdf | 0000000000-26-003830 | 333-294956 | 40036 | |||||
| 2026-04-10 | 4 | 4 | 0001193125-26-151632 | 7436 | ||||||
| 2026-04-10 | 4 | 4 | 0001193125-26-151628 | 4694 | ||||||
| 2026-04-10 | 4 | 4 | 0001193125-26-151626 | 4703 | ||||||
| 2026-04-09 | S-3 | S-3 | 0001193125-26-149869 | 333-294956 | 26852575 | 33 | 1175090 | 1 | 1 | |
| 2026-04-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-149822 | 001-41331 | 26852407 | 34 | 400725 | 1 | 1 |
| 2026-03-25 | D | xslFormDX01/primary_doc.xml | 06b | 0001880438-26-000001 | 021-577698 | 26793048 | 33 | 21142 | ||
| 2026-03-23 | 4 | 4 | 0001193125-26-120236 | 16750 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120235 | 16796 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120230 | 16208 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120226 | 12185 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120223 | 16217 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120221 | 16276 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120216 | 16210 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120214 | 16213 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120210 | 12797 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120207 | 16207 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120200 | 12159 | ||||||
| 2026-03-23 | 4 | 4 | 0001193125-26-120192 | 16796 | ||||||
| 2026-03-20 | 8-K | 8-K | 5.02 | 0001193125-26-117765 | 001-41331 | 26778728 | 34 | 142893 | 1 | 1 |
| 2026-03-17 | S-8 | S-8 | 0001193125-26-110791 | 333-294375 | 26761960 | 33 | 521965 | 1 | 1 | |
| 2026-03-17 | 10-K | 10-K | 0001193125-26-110693 | 001-41331 | 26761684 | 34 | 10409377 | 1 | 1 | |
| 2026-03-17 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-110681 | 001-41331 | 26761655 | 34 | 372214 | 1 | 1 |
| 2026-03-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001831942-26-000014 | 005-93617 | 26757048 | 34 | 15839 | |||
| 2026-03-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-027730 | 005-93617 | 26753342 | 34 | 19778 | |||
| 2026-03-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001213900-26-027660 | 005-93617 | 26752331 | 34 | 19809 | |||
| 2026-03-10 | 8-K | 8-K | 1.01,3.02,7.01,9.01 | 0001193125-26-099169 | 001-41331 | 26737019 | 34 | 632118 | 1 | 1 |
| 2026-03-05 | 4 | 4 | 0001193125-26-094490 | 5725 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064176 | 8004 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064174 | 7711 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064166 | 18687 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064151 | 10030 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064141 | 7699 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064105 | 5143 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064103 | 5163 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064089 | 5145 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064069 | 5152 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064061 | 5142 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064059 | 5131 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-064028 | 5211 | ||||||
| 2026-02-23 | 4 | 4 | 0001193125-26-063984 | 5148 | ||||||
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001596468-26-000004 | 005-93617 | 26644472 | 34 | 6470 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-26-051535 | 005-93617 | 26633530 | 34 | 6901 | |||
| 2026-02-03 | 3 | 3 | 0001193125-26-036046 | 7648 | ||||||
| 2026-01-29 | 8-K | 8-K | 5.02 | 0001193125-26-029540 | 001-41331 | 26578848 | 34 | 145354 | 1 | 1 |
| 2026-01-14 | 4 | 4 | 0001193125-26-013041 | 7300 | ||||||
| 2026-01-14 | 4 | 4 | 0001193125-26-013038 | 4566 | ||||||
| 2026-01-14 | 4 | 4 | 0001193125-26-013035 | 4558 | ||||||
| 2026-01-07 | 4 | 4 | 0001193125-26-006771 | 6817 | ||||||
| 2026-01-07 | 4 | 4 | 0001193125-26-006770 | 6960 | ||||||
| 2026-01-07 | 4 | 4 | 0001193125-26-006765 | 6863 | ||||||
| 2026-01-07 | 4 | 4 | 0001193125-26-006763 | 7310 | ||||||
| 2025-11-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001596468-25-000022 | 005-93617 | 251488955 | 34 | 6465 | |||
| 2025-11-12 | 10-Q | 10-Q | 0001193125-25-277673 | 001-41331 | 251473118 | 34 | 8771361 | 1 | 1 | |
| 2025-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-277662 | 001-41331 | 251473081 | 34 | 386983 | 1 | 1 |
| 2025-11-06 | 4 | 4 | 0001193125-25-270255 | 5492 | ||||||
| 2025-11-06 | 4 | 4 | 0001193125-25-270252 | 5432 | ||||||
| 2025-10-14 | 4 | 4 | 0001193125-25-238984 | 4555 | ||||||
| 2025-10-14 | 4 | 4 | 0001193125-25-238983 | 7297 | ||||||
| 2025-10-14 | 4 | 4 | 0001193125-25-238982 | 4563 | ||||||
| 2025-08-12 | 10-Q | 10-Q | 0000950170-25-107301 | 001-41331 | 251206655 | 34 | 8353682 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 9.01 | 0000950170-25-107278 | 001-41331 | 251206528 | 34 | 347871 | 1 | 1 |
| 2025-07-11 | 4 | 4 | 0000950170-25-095408 | 7295 | ||||||
| 2025-07-11 | 4 | 4 | 0000950170-25-095406 | 4552 | ||||||
| 2025-07-11 | 4 | 4 | 0000950170-25-095403 | 4560 | ||||||
| 2025-06-20 | 8-K | 8-K | 3.02,9.01 | 0001193125-25-143187 | 001-41331 | 251059052 | 34 | 257724 | 1 | 1 |
| 2025-06-18 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-25-000092 | 005-93617 | 251055520 | 34 | 8997 | |||
| 2025-06-16 | 4 | xslF345X05/form4.xml | 0001373604-25-000090 | 5002 | ||||||
| 2025-06-11 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-138796 | 001-41331 | 251038777 | 34 | 16245233 | 1 | 1 |
| 2025-06-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000935836-25-000414 | 005-93617 | 251024283 | 34 | 20565 | |||
| 2025-06-03 | 4 | 4 | 0000950170-25-081041 | 7963 | ||||||
| 2025-05-30 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-25-000086 | 005-93617 | 251012500 | 34 | 9038 | |||
| 2025-05-30 | 4 | xslF345X05/form4.xml | 0001373604-25-000084 | 9774 | ||||||
| 2025-05-29 | 4 | 4 | 0000950170-25-078982 | 4885 | ||||||
| 2025-05-27 | 8-K | 8-K | 5.07 | 0001193125-25-127595 | 001-41331 | 25989026 | 34 | 149674 | 1 | 1 |
| 2025-05-23 | 4 | 4 | 0000950170-25-077073 | 5154 | ||||||
| 2025-05-23 | 4 | 4 | 0000950170-25-077070 | 5143 | ||||||
| 2025-05-23 | 4 | 4 | 0000950170-25-077062 | 5202 | ||||||
| 2025-05-23 | 4 | 4 | 0000950170-25-077061 | 5139 | ||||||
| 2025-05-23 | 4 | 4 | 0000950170-25-077058 | 5168 | ||||||
| 2025-05-23 | 4 | 4 | 0000950170-25-077053 | 5141 | ||||||
| 2025-05-23 | 4 | 4 | 0000950170-25-077036 | 5134 | ||||||
| 2025-05-23 | 4 | 4 | 0000950170-25-077035 | 5121 | ||||||
| 2025-05-13 | 10-Q | 10-Q | 0000950170-25-070358 | 001-41331 | 25940236 | 34 | 7677963 | 1 | 1 | |
| 2025-05-13 | 8-K | 8-K | 9.01 | 0000950170-25-070305 | 001-41331 | 25939950 | 34 | 308437 | 1 | 1 |
| 2025-05-07 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001373604-25-000074 | 005-93617 | 25919814 | 34 | 13120 | |||
| 2025-05-01 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-110019 | 001-41331 | 25903676 | 34 | 179076 | 1 | 1 |
| 2025-04-11 | 4 | 4 | 0000950170-25-053373 | 5407 | ||||||
| 2025-04-11 | 4 | 4 | 0000950170-25-053367 | 7292 | ||||||
| 2025-04-11 | 4 | 4 | 0000950170-25-053355 | 4559 | ||||||
| 2025-04-11 | 4 | 4 | 0000950170-25-053348 | 4551 | ||||||
| 2025-04-11 | ARS | ARS | 0000950170-25-052971 | 001-41331 | 25829450 | 34 | 2236894 | |||
| 2025-04-10 | DEFA14A | DEFA14A | 0000950170-25-052853 | 001-41331 | 25828482 | 34 | 1129931 | |||
| 2025-04-10 | DEF 14A | DEF 14A | 0000950170-25-052852 | 001-41331 | 25828367 | 34 | 3686196 | 1 | 1 | |
| 2025-03-25 | S-8 | S-8 | 0000950170-25-044432 | 333-286094 | 25768688 | 33 | 530812 | 1 | 1 | |
| 2025-03-25 | 10-K | 10-K | 0000950170-25-044366 | 001-41331 | 25768334 | 34 | 10696094 | 1 | 1 | |
| 2025-03-25 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-044353 | 001-41331 | 25768239 | 34 | 345953 | 1 | 1 |
| 2025-02-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-030289 | 005-93617 | 25693139 | 34 | 114829 | |||
| 2025-02-28 | 4 | 4 | 0000950170-25-030057 | 7391 | ||||||
| 2025-02-28 | 4 | 4 | 0000950170-25-030052 | 7292 | ||||||
| 2025-02-28 | 4 | 4 | 0000950170-25-030042 | 7544 | ||||||
| 2025-02-28 | 4 | 4 | 0000950170-25-030041 | 9838 | ||||||
| 2025-02-28 | 4 | 4 | 0000950170-25-030032 | 7483 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-004263 | 005-93617 | 25631674 | 34 | 17069 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-021346 | 005-93617 | 25630152 | 34 | 113542 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-014185 | 005-93617 | 25629635 | 34 | 6591 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-003979 | 005-93617 | 25624934 | 34 | 37514 | |||
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-019942 | 005-93617 | 25620748 | 34 | 7084 | |||
| 2025-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001373604-25-000020 | 005-93617 | 25620714 | 34 | 6445 | |||
| 2025-01-07 | 4 | 4 | 0000950170-25-003160 | 5195 | ||||||
| 2025-01-07 | 4 | 4 | 0000950170-25-003157 | 5387 | ||||||
| 2025-01-07 | 4 | 4 | 0000950170-25-003153 | 5166 | ||||||
| 2025-01-07 | 4 | 4 | 0000950170-25-003152 | 5224 | ||||||
| 2024-12-23 | 4 | 4 | 0000950170-24-139804 | 4571 | ||||||
| 2024-12-23 | 4 | 4 | 0000950170-24-139800 | 7304 | ||||||
| 2024-12-23 | 4 | 4 | 0000950170-24-139797 | 4563 | ||||||
| 2024-12-23 | 4 | 4 | 0000950170-24-139793 | 5414 | ||||||
| 2024-12-23 | 4 | 4 | 0000950170-24-139792 | 7057 | ||||||
| 2024-12-10 | 4 | 4 | 0000950170-24-135150 | 16286 | ||||||
| 2024-11-27 | 4 | 4 | 0000950170-24-131660 | 12169 | ||||||
| 2024-11-27 | 4 | 4 | 0000950170-24-131499 | 5191 | ||||||
| 2024-11-21 | 4 | 4 | 0000950170-24-129830 | 11176 | ||||||
| 2024-11-20 | 4 | 4 | 0000950170-24-129248 | 6562 | ||||||
| 2024-11-18 | 4 | 4 | 0000950170-24-128202 | 7277 | ||||||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0000921895-24-002722 | 005-93617 | 241463058 | 34 | 266497 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-118948 | 005-93617 | 241462611 | 34 | 136477 | |||
| 2024-11-13 | SC 13G/A | SC 13G/A | 0001193125-24-257248 | 005-93617 | 241454725 | 34 | 60735 | |||
| 2024-11-13 | 10-Q | 10-Q | 0000950170-24-126282 | 001-41331 | 241453931 | 34 | 7473293 | 1 | 1 | |
| 2024-11-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-126276 | 001-41331 | 241453886 | 34 | 329092 | 1 | 1 |
| 2024-11-05 | 4 | 4 | 0000950170-24-121601 | 7697 | ||||||
| 2024-11-05 | 4 | 4 | 0000950170-24-121591 | 7958 | ||||||
| 2024-11-05 | 3 | 3 | 0000950170-24-121585 | 20591 | ||||||
| 2024-11-05 | 8-K | 8-K | 5.02 | 0001193125-24-251240 | 001-41331 | 241427428 | 34 | 149159 | 1 | 1 |
| 2024-08-28 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-015449 | 005-93617 | 241255364 | 34 | 68441 | |||
| 2024-08-19 | 8-A12B | 8-A12B | 0001193125-24-202437 | 001-41331 | 241218191 | 34 | 31540 | |||
| 2024-08-19 | 8-K | 8-K | 1.01,3.03,5.03,9.01 | 0001193125-24-202430 | 001-41331 | 241218175 | 34 | 617980 | 1 | 1 |
| 2024-08-15 | 144 | xsl144X01/primary_doc.xml | 0001178937-24-000045 | 001-41331 | 241213569 | 33 | 4541 | |||
| 2024-08-15 | 144 | xsl144X01/primary_doc.xml | 0001178937-24-000044 | 001-41331 | 241213548 | 33 | 4412 | |||
| 2024-08-14 | SC 13G/A | antx13g.htm | 0001373604-24-000073 | 005-93617 | 241210371 | 34 | 56828 | |||
| 2024-08-14 | 4 | xslF345X05/form4.xml | 0001373604-24-000066 | 4953 | ||||||
| 2024-08-13 | SC 13G/A | SC 13G/A | 0001104659-24-089067 | 005-93617 | 241203235 | 34 | 85517 | |||
| 2024-08-13 | 4 | xslF345X05/form4-08132024_090830.xml | 0001415889-24-021199 | 14610 | ||||||
| 2024-08-13 | 10-Q | 10-Q | 0000950170-24-096243 | 001-41331 | 241201675 | 34 | 7210938 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-096173 | 001-41331 | 241201397 | 34 | 287385 | 1 | 1 |
| 2024-08-12 | 3 | xslF345X02/form3.xml | 0001373604-24-000064 | 4166 | ||||||
| 2024-08-12 | SC 13G | antx13g.htm | 0001373604-24-000062 | 005-93617 | 241197553 | 34 | 56840 | |||
| 2024-08-08 | 8-K | 8-K | 2.05,5.02,7.01,8.01,9.01 | 0001193125-24-197047 | 001-41331 | 241189268 | 34 | 175722 | 1 | 1 |
| 2024-07-12 | 4 | 4 | 0000950170-24-083200 | 17663 | ||||||
| 2024-07-03 | SC 13G | x72241sc13g.htm | 0001214659-24-011905 | 005-93617 | 241098276 | 34 | 68465 | |||
| 2024-06-24 | 8-K | 8-K | 5.07,9.01 | 0001193125-24-166938 | 001-41331 | 241064290 | 34 | 199360 | 1 | 1 |
| 2024-06-21 | 4 | 4 | 0000950170-24-076410 | 17479 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076408 | 17909 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076406 | 17981 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076404 | 18447 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076399 | 18470 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076374 | 17943 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076369 | 17918 | ||||||
| 2024-06-21 | 4 | 4 | 0000950170-24-076361 | 18433 | ||||||
| 2024-05-14 | 10-Q | 10-Q | 0000950170-24-059556 | 001-41331 | 24944475 | 34 | 6751349 | 1 | 1 | |
| 2024-05-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-059527 | 001-41331 | 24944305 | 34 | 256869 | 1 | 1 |
| 2024-05-14 | 10-K/A | 10-K/A | 0000950170-24-059488 | 001-41331 | 24944081 | 34 | 1621637 | 1 | 1 | |
| 2024-04-26 | ARS | ARS | 0000950170-24-049195 | 001-41331 | 24884214 | 34 | 2485062 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0000950170-24-049172 | 001-41331 | 24884085 | 34 | 1824369 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0000950170-24-049148 | 001-41331 | 24883944 | 34 | 4091893 | |||
| 2024-04-10 | SC 13G | SC 13G | 0001193125-24-091977 | 005-93617 | 24836351 | 34 | 326832 | |||
| 2024-04-05 | PRE 14A | PRE 14A | 0000950170-24-042271 | 001-41331 | 24826658 | 34 | 1142279 | |||
| 2024-03-29 | S-8 | S-8 | 0000950170-24-038752 | 333-278399 | 24804749 | 33 | 219914 | |||
| 2024-03-29 | 10-K | 10-K | 0000950170-24-038681 | 001-41331 | 24804379 | 34 | 9448568 | 1 | 1 | |
| 2024-03-29 | 4/A | xslF345X05/form4.xml | 0001610717-24-000196 | 4662 | ||||||
| 2024-03-29 | 4/A | xslF345X05/form4.xml | 0001610717-24-000195 | 4618 | ||||||
| 2024-03-29 | 4/A | xslF345X05/form4.xml | 0001610717-24-000194 | 4662 | ||||||
| 2024-03-29 | 4/A | xslF345X05/form4.xml | 0001610717-24-000193 | 16037 | ||||||
| 2024-03-29 | 4/A | xslF345X05/form4.xml | 0001610717-24-000192 | 4714 | ||||||
| 2024-03-29 | 4/A | xslF345X05/form4.xml | 0001610717-24-000191 | 24750 | ||||||
| 2024-03-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-038055 | 001-41331 | 24799131 | 34 | 307628 | 1 | 1 |
| 2024-03-18 | 4 | xslF345X05/form4.xml | 0001610717-24-000169 | 6970 | ||||||
| 2024-03-18 | 4 | xslF345X05/form4.xml | 0001610717-24-000168 | 7255 | ||||||
| 2024-03-18 | 4 | xslF345X05/form4.xml | 0001610717-24-000167 | 18152 | ||||||
| 2024-03-18 | 4 | xslF345X05/form4.xml | 0001610717-24-000166 | 7068 | ||||||
| 2024-03-18 | 4 | xslF345X05/form4.xml | 0001610717-24-000165 | 7008 | ||||||
| 2024-03-18 | 4 | xslF345X05/form4.xml | 0001610717-24-000164 | 29458 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023990 | 005-93617 | 24640171 | 34 | 88755 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023929 | 005-93617 | 24639966 | 34 | 137732 | |||
| 2024-02-14 | SC 13G/A | SC 13G A AN2 | 0000078003-24-000031 | 005-93617 | 24636140 | 34 | 52370 | |||
| 2024-02-13 | SC 13G | SC 13G | 0001193125-24-033944 | 005-93617 | 24629179 | 34 | 41160 | |||
| 2024-02-12 | SC 13G/A | JHG PLC AND JHBIF OWN <5% | 0001274173-24-000020 | 005-93617 | 24619066 | 34 | 12626 | |||
| 2024-02-12 | 8-K | 8-K | 8.01 | 0001193125-24-031008 | 001-41331 | 24617335 | 34 | 158074 | 1 | 1 |
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001193125-24-030111 | 005-93617 | 24615465 | 34 | 57382 | |||
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001193125-24-029181 | 005-93617 | 24611132 | 34 | 91124 | |||
| 2024-01-19 | 4 | 4 | 0000950170-24-005900 | 17166 | ||||||
| 2024-01-18 | 4 | 4 | 0000950170-24-005515 | 7346 | ||||||
| 2024-01-18 | 4 | 4 | 0000950170-24-005513 | 13083 | ||||||
| 2024-01-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000370 | 001-41331 | 24542363 | 33 | 4693 | |||
| 2024-01-17 | 4 | FORM 4 SUBMISSION | 0001209191-24-001770 | 8886 | ||||||
| 2024-01-16 | 144 | xsl144X01/primary_doc.xml | 0001961863-24-000003 | 001-41331 | 24536164 | 33 | 5874 | |||
| 2024-01-16 | 144 | xsl144X01/primary_doc.xml | 0001961863-24-000002 | 001-41331 | 24536142 | 33 | 5869 | |||
| 2024-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-24-001537 | 13278 | ||||||
| 2024-01-11 | 4 | xslF345X05/form4.xml | 0001610717-24-000027 | 12372 | ||||||
| 2024-01-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000261 | 001-41331 | 24526732 | 33 | 5064 | |||
| 2024-01-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000260 | 001-41331 | 24526731 | 33 | 5071 | |||
| 2024-01-04 | 4 | xslF345X05/form4.xml | 0001610717-24-000014 | 20484 | ||||||
| 2024-01-04 | 4 | xslF345X05/form4.xml | 0001610717-24-000013 | 27121 | ||||||
| 2024-01-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000081 | 001-41331 | 24503136 | 33 | 4685 | |||
| 2024-01-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000053 | 001-41331 | 24503008 | 33 | 4720 | |||
| 2023-11-16 | 4 | 4 | 0000950170-23-064611 | 13584 | ||||||
| 2023-11-16 | 4 | 4 | 0000950170-23-064609 | 7997 | ||||||
| 2023-11-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004936 | 001-41331 | 231406331 | 33 | 11138 | |||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062081 | 001-41331 | 231392645 | 34 | 8468383 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-062046 | 001-41331 | 231392463 | 34 | 362892 | 1 | 1 |
| 2023-10-03 | 4 | 4 | 0000950170-23-051733 | 11726 | ||||||
| 2023-10-03 | 4 | 4 | 0000950170-23-051728 | 17155 | ||||||
| 2023-10-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004323 | 001-41331 | 231299731 | 33 | 10360 | |||
| 2023-09-29 | 4 | 4 | 0000950170-23-050853 | 17150 | ||||||
| 2023-09-29 | 4 | 4 | 0000950170-23-050851 | 11723 | ||||||
| 2023-09-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004305 | 001-41331 | 231295648 | 33 | 9583 | |||
| 2023-09-15 | 4 | 4 | 0000950170-23-048436 | 7475 | ||||||
| 2023-09-15 | 4 | 4 | 0000950170-23-048422 | 13066 | ||||||
| 2023-09-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-233934 | 001-41331 | 231251634 | 34 | 164832 | 1 | 1 |
| 2023-09-08 | 4 | 4 | 0000950170-23-047312 | 17154 | ||||||
| 2023-09-08 | 4 | 4 | 0000950170-23-047311 | 11723 | ||||||
| 2023-09-08 | 8-K | 8-K | 5.02 | 0001193125-23-230786 | 001-41331 | 231243185 | 34 | 146189 | 1 | 1 |
| 2023-08-25 | 4 | 4 | 0000950170-23-044594 | 12838 | ||||||
| 2023-08-25 | 4 | 4 | 0000950170-23-044593 | 7259 | ||||||
| 2023-08-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-003395 | 001-41331 | 231197741 | 33 | 4917 | |||
| 2023-08-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-094274 | 13350 | ||||||
| 2023-08-16 | 424B5 | 424B5 | 0001193125-23-214364 | 333-271174 | 231178788 | 33 | 437254 | |||
| 2023-08-16 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-23-214362 | 001-41331 | 231178756 | 34 | 467936 | 1 | 1 |
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-041378 | 001-41331 | 231159938 | 34 | 8478091 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-041358 | 001-41331 | 231159757 | 34 | 387321 | 1 | 1 |
| 2023-07-25 | SC 13G | SC 13G | 0001193125-23-193456 | 005-93617 | 231108778 | 34 | 76145 | |||
| 2023-07-05 | SC 13G | BIOTECH (NON-RIC) OWNS 5% | 0001274173-23-000083 | 005-93617 | 231070119 | 34 | 12822 | |||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015326 | 9103 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015321 | 9132 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015320 | 9198 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015317 | 9128 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015314 | 9129 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015313 | 9132 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015310 | 9158 | ||||||
| 2023-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-23-015307 | 5447 | ||||||
| 2023-06-09 | 8-K | 8-K | 5.07 | 0001193125-23-164459 | 001-41331 | 231005406 | 34 | 157793 | 1 | 1 |
| 2023-05-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-013012 | 10751 | ||||||
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021291 | 001-41331 | 23911395 | 34 | 7898608 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-021275 | 001-41331 | 23911325 | 34 | 336485 | 1 | 1 |
| 2023-04-26 | ARS | ARS | 0000950170-23-014842 | 001-41331 | 23850119 | 34 | 9418197 | |||
| 2023-04-26 | DEFA14A | DEFA14A | 0000950170-23-014813 | 001-41331 | 23849921 | 34 | 1146488 | |||
| 2023-04-26 | DEF 14A | DEF 14A | 0000950170-23-014794 | 001-41331 | 23849748 | 34 | 2816305 | |||
| 2023-04-14 | 424B5 | 424B5 | 0001193125-23-100832 | 333-271174 | 23819469 | 33 | 459776 | |||
| 2023-04-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-04-13 16:00:00 | 9999999995-23-000930 | 333-271174 | 23819590 | 33 | 1687 | ||
| 2023-04-11 | CORRESP | filename1.htm | 0001193125-23-097786 | 7065 | ||||||
| 2023-04-10 | UPLOAD | filename1.pdf | 0000000000-23-003544 | 40180 | ||||||
| 2023-04-06 | S-3 | S-3 | 0001193125-23-094152 | 333-271174 | 23807026 | 33 | 1393495 | |||
| 2023-03-30 | S-8 | S-8 | 0001193125-23-084122 | 333-270962 | 23776963 | 33 | 88779 | |||
| 2023-03-29 | 10-K | 10-K | 0000950170-23-010627 | 001-41331 | 23775551 | 34 | 11198030 | 1 | 1 | |
| 2023-03-29 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-010615 | 001-41331 | 23775413 | 34 | 424630 | 1 | 1 |
| 2023-02-24 | 4 | FORM 4 SUBMISSION | 0000899243-23-006150 | 5315 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-005558 | 5281 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-005557 | 5377 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-005555 | 5325 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-005554 | 5325 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-005550 | 5345 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0000899243-23-005545 | 5345 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021812 | 005-93617 | 23630735 | 34 | 77642 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000525 | 005-93617 | 23624975 | 34 | 277119 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020803 | 005-93617 | 23622814 | 34 | 140771 | |||
| 2023-02-13 | SC 13G | SC 13G AN2 THERAPEUTICS | 0000078003-23-000011 | 005-93617 | 23619743 | 34 | 75379 | |||
| 2023-02-13 | SC 13G | SC 13G | 0001104659-23-019766 | 005-93617 | 23619287 | 34 | 35554 | |||
| 2023-02-10 | SC 13G | SC 13G | 0001193125-23-032801 | 005-93617 | 23613093 | 34 | 92596 | |||
| 2022-11-14 | 4 | FORM 4 SUBMISSION | 0000899243-22-035782 | 10349 | ||||||
| 2022-11-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-035472 | 11498 | ||||||
| 2022-11-09 | 10-Q | 10-Q | 0000950170-22-023901 | 001-41331 | 221372985 | 34 | 9637447 | 1 | 1 | |
| 2022-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023882 | 001-41331 | 221372889 | 34 | 363814 | 1 | 1 |
| 2022-11-07 | 4 | FORM 4 SUBMISSION | 0000899243-22-035311 | 14618 | ||||||
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-034840 | 9942 | ||||||
| 2022-10-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-034497 | 9939 | ||||||
| 2022-10-28 | 4 | FORM 4 SUBMISSION | 0000899243-22-034442 | 5395 | ||||||
| 2022-10-26 | 4 | FORM 4 SUBMISSION | 0000899243-22-034294 | 13040 | ||||||
| 2022-10-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-034092 | 13053 | ||||||
| 2022-10-06 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-258534 | 001-41331 | 221297092 | 34 | 167531 | 1 | 1 |
| 2022-10-05 | 3 | FORM 3 SUBMISSION | 0000899243-22-033045 | 6608 | ||||||
| 2022-08-11 | 10-Q | 10-Q | 0000950170-22-016900 | 001-41331 | 221156232 | 34 | 8882338 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016887 | 001-41331 | 221156131 | 34 | 350429 | 1 | 1 |
| 2022-08-05 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-086686 | 14706 | ||||||
| 2022-07-28 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-083728 | 14989 | ||||||
| 2022-06-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-185058 | 001-41331 | 221054783 | 34 | 164288 | 1 | 1 |
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024054 | 8013 | ||||||
| 2022-06-24 | 4 | FORM 4 SUBMISSION | 0000899243-22-024050 | 13552 | ||||||
| 2022-06-24 | 4/A | FORM 4/A SUBMISSION | 0000899243-22-024034 | 27665 | ||||||
| 2022-06-24 | 3/A | FORM 3/A SUBMISSION | 0000899243-22-024031 | 14987 | ||||||
| 2022-06-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-073920 | 12870 | ||||||
| 2022-06-15 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-071465 | 14751 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018296 | 5376 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018293 | 5292 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018292 | 5324 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018290 | 5281 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018289 | 5279 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018287 | 5344 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018286 | 5334 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018282 | 5260 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018281 | 5305 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018278 | 5344 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018276 | 5280 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018273 | 5277 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018272 | 5272 | ||||||
| 2022-05-16 | 4 | FORM 4 SUBMISSION | 0000899243-22-018271 | 5314 | ||||||
| 2022-05-10 | 10-Q | 10-Q | 0000950170-22-008999 | 001-41331 | 22910076 | 34 | 7763143 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-008992 | 001-41331 | 22909902 | 34 | 346848 | 1 | 1 |
| 2022-05-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-017371 | 5312 | ||||||
| 2022-05-09 | 3 | FORM 3 SUBMISSION | 0000899243-22-017369 | 6603 | ||||||
| 2022-05-09 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-145000 | 001-41331 | 22905148 | 34 | 25002 | ||
| 2022-04-08 | SC 13G | AN2 THERAPEUTICS, INC. | 0001104659-22-044249 | 005-93617 | 22817440 | 34 | 77451 | |||
| 2022-04-08 | SC 13G | AN2 THERAPEUTICS, INC. | 0001104659-22-044208 | 005-93617 | 22817115 | 34 | 133481 | |||
| 2022-04-04 | SC 13G | THE SCHEDULE 13G | 0000921895-22-001065 | 005-93617 | 22802937 | 34 | 285810 | |||
| 2022-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-22-012992 | 6991 | ||||||
| 2022-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-22-012991 | 24171 | ||||||
| 2022-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-22-012990 | 24993 | ||||||
| 2022-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-22-012989 | 7024 | ||||||
| 2022-03-31 | 4 | FORM 4 SUBMISSION | 0000899243-22-012988 | 22701 | ||||||
| 2022-03-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-041080 | 22584 | ||||||
| 2022-03-29 | S-8 | S-8 | 0001193125-22-086928 | 333-263917 | 22776749 | 33 | 108802 | |||
| 2022-03-28 | 424B4 | 424B4 | 0001193125-22-085459 | 333-263295 | 22773008 | 33 | 3874230 | |||
| 2022-03-24 | SEC STAFF LETTER | filename1.pdf | 9999999997-22-001197 | 274805 | ||||||
| 2022-03-24 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-03-24 16:00:00 | 9999999995-22-000716 | 333-263295 | 22768126 | 33 | 1687 | ||
| 2022-03-24 | S-1MEF | S-1MEF | 0001193125-22-084274 | 333-263840 | 22768108 | 33 | 68319 | |||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012182 | 11829 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012181 | 7894 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012180 | 7860 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012179 | 10075 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012175 | 9671 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012174 | 13032 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012173 | 7968 | ||||||
| 2022-03-24 | 3 | OWNERSHIP DOCUMENT | 0001104659-22-037672 | 13421 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012170 | 8622 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012167 | 12754 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012164 | 11837 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012163 | 11087 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012162 | 10632 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012158 | 15225 | ||||||
| 2022-03-24 | 3 | FORM 3 SUBMISSION | 0000899243-22-012157 | 7856 | ||||||
| 2022-03-24 | CERT | 8A_Cert_ANTX.pdf | 0001354457-22-000197 | 001-41331 | 22765238 | 34 | 215528 | |||
| 2022-03-22 | 8-A12B | 8-A12B | 0001193125-22-081697 | 001-41331 | 22760307 | 34 | 13327 | |||
| 2022-03-22 | CORRESP | filename1.htm | 0001193125-22-081637 | 10590 | ||||||
| 2022-03-22 | CORRESP | filename1.htm | 0001193125-22-081632 | 7849 | ||||||
| 2022-03-21 | S-1/A | S-1/A | 0001193125-22-080012 | 333-263295 | 22754177 | 33 | 4957218 | |||
| 2022-03-10 | SEC STAFF LETTER | filename1.pdf | 9999999997-22-000786 | 276091 | ||||||
| 2022-03-04 | S-1 | REGISTRATION STATEMENT ON FORM S-1 | 0001193125-22-066048 | 333-263295 | 22713992 | 33 | 6460394 | |||
| 2022-01-19 | DRSLTR | filename1.htm | 0000950123-22-000334 | 32059 | ||||||
| 2022-01-19 | DRS/A | filename1.htm | 0000950123-22-000333 | 377-05527 | 22539132 | 33 | 3835665 | |||
| 2021-12-03 | UPLOAD | filename1.pdf | 0000000000-21-014591 | 48412 | ||||||
| 2021-11-19 | DRS/A | filename1.htm | 0000950123-21-015729 | 377-05527 | 211426253 | 33 | 3600553 | |||
| 2021-11-18 | DRSLTR | filename1.htm | 0000950123-21-015730 | 55090 | ||||||
| 2021-10-22 | UPLOAD | filename1.pdf | 0000000000-21-012872 | 65781 | ||||||
| 2021-09-24 | DRS | filename1.htm | 0000950123-21-012609 | 377-05527 | 211278120 | 33 | 4331253 |
One latest value per concept from companyfacts (184 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 37.94M | 2026-11-05 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 23.08M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 964.97 | 2026-09-14 | S-8 | 2026-09-14 | 0001880438-26-000002 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 964.97 | 2026-09-14 | S-8 | 2026-09-14 | 0001880438-26-000002 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 6.99M | 2026-09-14 | S-8 | 2026-09-14 | 0001880438-26-000002 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-04-09 | S-3 | 2026-04-09 | 0001193125-26-149869 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-04-09 | S-3 | 2026-04-09 | 0001193125-26-149869 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 377,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 2.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -207,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 342.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 973,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 8.10M | 2022-01-01 | 2022-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021291 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 3.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062081 | |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 1,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008999 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 7.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | Assets | Assets | USD | 81.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 65.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0000950170-22-016900 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 44.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 15.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | CapitalizedContractCostAmortization | Capitalized Contract Cost, Amortization | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062081 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 20.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 70.42M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008999 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 95.30M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-10 | 0000950170-23-041378 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 20.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 266,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 82.50M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008999 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2025-06-30 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 2.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 18.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 37.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 37.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -26.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 111.14M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestWriteoff | Debt Securities, Available-for-Sale, Accrued Interest Writeoff | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | Security | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | 300,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 5.34M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 55.75M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 28.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 228,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 7.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 4.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 55.75M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.63 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -2.98 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008999 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.63 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.226 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 360,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.007 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.184 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.02 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 1.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 3.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008999 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008999 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 9.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-14 | 0000950170-24-059556 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 7.96M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -7.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 84,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 360,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-25 | 0000950170-25-044366 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -6.48M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 718,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -1.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -2,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -53,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-25 | 0000950170-25-044366 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | -284,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | 170,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 720,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -489,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 1.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 1.35M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 |
| us-gaap | Investments | Investments | USD | 60.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 161,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 54,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 54,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 20,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023901 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 | |
| us-gaap | Liabilities | Liabilities | USD | 6.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 81.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 6.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 45.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -19.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -25.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -26.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -26.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 28.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -28.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 54,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 50,000 | 2022-01-01 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 53,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 50,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 50,000 | 2022-01-01 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062081 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.051 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 42,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 387,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -264,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -184,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 945,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 170,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -1,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings | Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 2.20M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 1.21M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 49.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | PreferredStockDividendsAndOtherAdjustments | Preferred Stock Dividends and Other Adjustments | USD | 1.82M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 1.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 70.37M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 86,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 79.73M | 2021-01-01 | 2021-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008999 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 29.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 243,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 111,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -26.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | RelatedPartyCosts | Related Party Costs | USD | 0 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-10 | 0000950170-23-041378 |
| us-gaap | RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty | Related Party Transaction, Expenses from Transactions with Related Party | USD | 500,000 | 2022-01-01 | 2022-06-30 | 2023 | Q2 | 10-Q | 2023-08-10 | 0000950170-23-041378 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 18.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.5 | 2024-08-08 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 2.23M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 500,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-126282 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -267.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 3.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | USD | 0 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-12 | 0001193125-25-277673 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.09 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.042 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 7.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 4.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 7.28 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 44,864 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 6.18 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 524,026 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-126282 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.58 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 14.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 6.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 5.74 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 1.60M | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0000950170-22-016900 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 400,000 | 2026-03-19 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.26 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 8.78 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-126282 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.86 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 107,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 75.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 2.353 | 2022-03-17 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 107,633 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 111.14M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 72,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 65.48M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-25 | 0000950170-25-044366 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 165,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 109.32M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 103.06M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 11.41M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 11.41M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-29 | 0000950170-23-010627 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-29 | 0000950170-24-038681 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 10.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 249,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 8.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | -2.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-17 | 0001193125-26-110693 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 41.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 3.18M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0000950170-22-008999 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 41.69M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-09 | 0001193125-26-452664 |